Search Results - "Portlock, C"

Long-term outcome of 487 patients with early-stage extra-nodal marginal zone lymphoma by Teckie, S., Qi, S., Chelius, M., Lovie, S., Hsu, M., Noy, A., Portlock, C., Yahalom, J.

“…Localized early-stage extra-nodal marginal zone lymphoma (MZL) presents with heterogeneous organ involvement and is treated with various modalities, including…”
Get full text

The majority of transformed lymphomas have high standardized uptake values (SUVs) on positron emission tomography (PET) scanning similar to diffuse large B-cell lymphoma (DLBCL) by Noy, A., Schöder, H., Gönen, M., Weissler, M., Ertelt, K., Cohler, C., Portlock, C., Hamlin, P., Yeung, H. W. D.

“…Background: We previously correlated non-Hodgkin's lymphoma (NHL) histology with 18fluoro-2-deoxyglucose–positron emission tomography (FDG–PET) intensity: a…”
Get full text

Is the inter-rater reliability of hip and shoulder strength testing different between hand-held and portable fixed dynamometers? by Portlock, C., Browne, M., Jhala, P., Fuller, J.

Get full text

Prognostic impact of proliferative index determined by quantitative image analysis and the International Prognostic Index in patients with mantle cell lymphoma by Schaffel, R., Hedvat, C. V., Teruya-Feldstein, J., Persky, D., Maragulia, J., Lin, D., Portlock, C. S., Moskowitz, C. H., Zelenetz, A. D.

“…Background: The proliferative index (PI) is a powerful prognostic factor in mantle cell lymphoma (MCL); however, its utility is hampered by interobserver…”
Get full text

Whole‐body diffusion‐weighted MR imaging in lymphoma surveillance by Rademaker, J., Ryan, D., Matasar, M., Portlock, C.

Get full text

Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone by Schechter, N R, Portlock, C S, Yahalom, J

“…Mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach (MLS) has recently been defined as a distinct clinicopathologic entity, often associated with…”
Get more information

CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients by Teruya-Feldstein, J., Chiao, E., Filippa, D. A., Lin, O., Comenzo, R., Coleman, M., Portlock, C., Noy, A.

“…Background: Plasmablastic lymphoma (PBL) has been described as a rapidly progressive and almost invariably fatal CD20– VS38c+ diffuse large-cell lymphoma with…”
Get full text

Noninvasive Monitoring of Mantle Cell Lymphoma by Immunoglobulin Gene Next-Generation Sequencing in a Phase 2 Study of Sequential Chemoradioimmunotherapy Followed by Autologous Stem-Cell Rescue by Kumar, Anita, Bantilan, K.S., Jacob, A.P., Park, A., Schoninger, S.F., Sauter, C., Ulaner, G.A., Casulo, C., Faham, M., Kong, K.A., Grewal, R.K., Gerecitano, J., Hamilton, A., Hamlin, P., Matasar, M., Moskowitz, C.H., Noy, A., Palomba, M.L., Portlock, C.S., Younes, A., Willis, T., Zelenetz, A.D.

“…Minimal residual disease (MRD) monitoring has been used to identify early molecular relapse and predict clinical relapse in mantle cell lymphoma (MCL). Few…”
Get full text

Stanford V program for locally extensive and advanced Hodgkin lymphoma: the Memorial Sloan-Kettering Cancer Center experience by Edwards-Bennett, S.M., Jacks, L.M., Moskowitz, C.H., Wu, E.J., Zhang, Z., Noy, A., Portlock, C.S., Straus, D.J., Zelenetz, A.D., Yahalom, J.

“…The Stanford group has reported excellent results with the Stanford V regimen for patients with bulky and/or advanced Hodgkin lymphoma (HL). However, Gobbi…”
Get full text

Anti-angiogenesis and diffuse large B-cell lymphoma: a new treatment opportunity? by Portlock, C.

Get full text

IMPACT OF PET IMAGING AND HISTOLOGIC TRANSFORMATION ON THE PROGNOSIS OF EARLY DISEASE PROGRESSION IN FOLLICULAR LYMPHOMA by Batlevi, C.L., Sha, F., Alperovich, A., Ni, A., Smith, K., Ying, Z., Hamlin, P., Horwitz, S.M., Kumar, A., Matasar, M., Moskowitz, A.J., Moskowitz, C.H., Noy, A., Palomba, M.L., Portlock, C., Straus, D., Boccomini, C., Tucci, A., Zelenetz, A.D., Seshan, V.E., Luminari, S., Marcheselli, L., Federico, M., Younes, A.

Get full text

Ifosfamide, Carboplatin, and Etoposide: A Highly Effective Cytoreduction and Peripheral-Blood Progenitor-Cell Mobilization Regimen for Transplant-Eligible Patients With Non-Hodgkin's Lymphoma by MOSKOWITZ, C. H, BERTINO, J. R, O'BRIEN, J, PORTLOCK, C. S, STRAUS, D. S, CHILDS, B, FRANK, R, YAHALOM, J, FILIPPA, D, LOUIE, D, NIMER, S. D, ZELENETZ, A. D, GLASSMAN, J. R, HEDRICK, E. E, HUNTE, S, COADY-LYONS, N, AGUS, D. B, GOY, A, JURCIC, J, NOY, A

“…To evaluate a chemotherapy regimen that consisted of ifosfamide administered as an infusion with bolus carboplatin, and etoposide (ICE) supported by…”
Get full text

Maintaining the dose intensity of ICE chemotherapy with a thrombopoietic agent, PEG-rHuMGDF, may confer a survival advantage in relapsed and refractory aggressive non-Hodgkin lymphoma by Moskowitz, C. H., Hamlin, P. A., Gabrilove, J., Bertino, J. R., Portlock, C. S., Straus, D. J., Gencarelli, A. N., Nimer, S. D., Zelenetz, A. D.

“…Introduction: HDT/ASCT is standard for relapsed and refractory DLCL patients responding to second-line chemotherapy. We incorporated a thrombopoietic agent…”
Get full text

DEFINING PROGRESSION FREE SURVIVAL AFTER MULTIPLE LINES OF THERAPY AND IMPACT OF DYNAMIC CHANGES IN FLIPI FOR MULTIPLY RELAPSED FOLLICULAR LYMPHOMA IN THE RITUXIMAB ERA by Batlevi, C., Alperovich, A., Ni, A., Soumerai, J., Smith, K., Ying, Z., Caron, P., Drullinsky, P., Gerecitano, J., Hamilton, A., Hamlin, P., Horwitz, S., Kumar, A., Matasar, M., Moskowitz, A., Moskowitz, C., Noy, A., Palomba, M., Portlock, C., Sauter, C., Straus, D., Zelenetz, A., Seshan, V., Younes, A.

Get full text

comparison of the autecology of two seed-taking ant genera, Rhytidoponera and Melophorus by Majer, J. D, Gove, A. D, Sochacki, S, Searle, P, Portlock, C

“…Members of the genus Rhytidoponera and, to a lesser extent, certain Melophorus spp. are keystone mutualists for the dispersal of seeds in the southwest of…”
Get full text

TIME FROM DIAGNOSIS TO 2ND TREATMENT IS A PROMISING SURROGATE FOR OVERALL SURVIVAL IN PATIENTS WITH ADVANCED STAGE FOLLICULAR LYMPHOMA by Soumerai, J.D., Ni, A., Batlevi, C., Alperovich, A., Bantilan, K.S., Palomba, M., Gerecitano, J.F., Noy, A., Hamlin, P., Moskowitz, C.H., Copeland, A.R., Matasar, M.J., Drullinsky, P.R., Hamilton, A., Horwitz, S.M., Intlekofer, A.M., Kumar, A., Moskowitz, A., Portlock, C., Sauter, C., Straus, D.J., Caron, P., Ying, Z., Smith, K., Younes, A., Zelenetz, A.D.

Get full text

Infectious disease associations in advanced stage, indolent lymphoma (follicular and nonfollicular): developing a lymphoma prevention strategy by Portlock, C. S., Hamlin, P., Noy, A., Chey, W., Gaydos, C. A., Palomba, L., Schwartz, I., Corcoran, S., Rosenzweig, L., Walker, D., Papanicolaou, G., Markowitz, A.

“…Background: Eradication of Helicobacter pylori in gastric mucosa-associated lymphoid tumor can result in lymphoma remission. We prospectively…”
Get full text

Endoscopic ultrasound in the evaluation of gastric small lymphocytic mucosa-associated lymphoid tumors by Pavlick, A C, Gerdes, H, Portlock, C S

“…Low-grade, small lymphocytic lymphomas of the mucosa-associated lymphoid tissue (MALT) have recently been shown to be associated with Helicobacter pylori…”
Get more information

Effect of ABVD chemotherapy with and without mantle or mediastinal irradiation on pulmonary function and symptoms in early-stage Hodgkin's disease by Hirsch, A, Vander Els, N, Straus, D J, Gomez, E G, Leung, D, Portlock, C S, Yahalom, J

“…To evaluate the effect of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) chemotherapy alone and of ABVD with mantle or mediastinal irradiation…”
Get more information

A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model by Moskowitz, Craig H., Nimer, Stephen D., Zelenetz, Andrew D., Trippett, Tania, Hedrick, Eric E., Filippa, Daniel A., Louie, Diane, Gonzales, Maria, Walits, Janine, Coady-Lyons, Nancy, Qin, Jing, Frank, Richard, Bertino, Joseph R., Goy, Andre, Noy, Ariela, O'Brien, James P., Straus, David, Portlock, Carol S., Yahalom, Joachim

“…Salvage of patients with relapsed and refractory Hodgkin disease (HD) with high-dose chemoradiotherapy (HDT) and autologous stem cell transplantation (ASCT)…”
Get full text